Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Otogenetics Hearing Loss and Deafness Multi-Gene NGS Panel Otogenetics United States | 123 | 129 |
|
EYA4 - NGS including CNV analysis Centogene US, LLC - The Rare Disease Company United States | 2 | 1 |
|
EYA4 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Invitae Comprehensive Deafness Panel Invitae United States | 405 | 219 |
|
Molecular Otolaryngology and Renal Research Laboratories University of Iowa Hospital and Clinics United States | 288 | 218 |
|
Intergen Genetic Diagnosis and Research Centre Turkey | 1 | 1 |
|
Hereditary Hearing Loss and Deafness Panel PreventionGenetics United States | 356 | 209 |
|
Ambry Genetics United States | 101 | 37 |
|
Ambry Genetics United States | 237 | 167 |
|
Ambry Genetics United States | 139 | 56 |
|
Ambry Genetics United States | 190 | 92 |
|
PreventionGenetics United States | 63 | 49 |
|
Deafness, Autosomal Dominant 10 (DFNA10) via the EYA4 Gene PreventionGenetics United States | 1 | 1 |
|
Invitae Dilated Cardiomyopathy and Left Ventricular Noncompaction Panel Invitae United States | 135 | 54 |
|
Invitae Cardiomyopathy Comprehensive Panel Invitae United States | 199 | 82 |
|
Invitae Arrhythmia and Cardiomyopathy Comprehensive Panel Invitae United States | 240 | 100 |
|
IGENOMIX Spain | 2 | 1 |
|
IGENOMIX Spain | 2 | 1 |
|
Baylor Genetics United States | 842 | 637 |
|
Autosomal Dominant Hearing Loss. 25-gene NGS panel. Genologica Medica Spain | 48 | 23 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.